Semax Consent Template
$599
Semax is an investigational synthetic peptide originally developed in Russia, derived from a fragment of adrenocorticotropic hormone (ACTH). It is being explored for its potential to support cognitive function, mental clarity, focus, and neuroprotection — with additional interest in its role in stress resilience and mood regulation.
Before beginning treatment, all patients complete a comprehensive informed consent process covering how Semax works, its experimental status, potential benefits, known side effects, contraindications, and patient responsibilities. As Semax is not FDA-approved and clinical evidence in Western medicine remains limited, all use is considered experimental and is conducted under qualified medical supervision.
